Bevacizumab as a treatment option in gastrointestinal bleeding associated to hereditary hemorrhagic telangiectasia. Case Report [Bevacizumab como opción terapéutica en sangrado gastrointestinal asociado a telangiectasia hemorrágica hereditaria. Reporte de caso]

Share this

Date

2019

Author

Castillo E.

Prada-Arismendy J.

Cite document

Citation

APA  IEEE  MLA  Chicago  Vancouver

CopiarCerrar

TY - GEN T1 - Bevacizumab as a treatment option in gastrointestinal bleeding associated to hereditary hemorrhagic telangiectasia. Case Report [Bevacizumab como opción terapéutica en sangrado gastrointestinal asociado a telangiectasia hemorrágica hereditaria. Reporte de caso] AU - Castillo E. AU - Prada-Arismendy J. Y1 - 2019 UR - http://hdl.handle.net/20.500.12622/3143 AB - ER - @misc{20.500.12622_3143, author = {Castillo E. and Prada-Arismendy J.}, title = {Bevacizumab as a treatment option in gastrointestinal bleeding associated to hereditary hemorrhagic telangiectasia. Case Report [Bevacizumab como opción terapéutica en sangrado gastrointestinal asociado a telangiectasia hemorrágica hereditaria. Reporte de caso]}, year = {2019}, abstract = {}, url = {http://hdl.handle.net/20.500.12622/3143} }RT Generic T1 Bevacizumab as a treatment option in gastrointestinal bleeding associated to hereditary hemorrhagic telangiectasia. Case Report [Bevacizumab como opción terapéutica en sangrado gastrointestinal asociado a telangiectasia hemorrágica hereditaria. Reporte de caso] A1 Castillo E. A1 Prada-Arismendy J. YR 2019 LK http://hdl.handle.net/20.500.12622/3143 AB OL Spanish (121)

Bibliographic managers

Refworks

Zotero

BibTeX

CiteULike

Metadata

Show full item record

Source

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073739486&doi=10.15446%2frevfacmed.v67n3.68417&partnerID=40&md5=7c45a39e018fe8d40526746065db9a08

URI

http://hdl.handle.net/20.500.12622/3143

Collections

• Artículos [930]